Updated (2018) ASCO/CAP Guidelines for HER2 Testing in Breast Cancer - Insights
The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines | Journal of Clinical Pathology
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update | Journal of Clinical Oncology
Second act for HER2, in gastric cancers - CAP TODAY
Mapping knowledgebase-specific evidence codes to AMP/ASCO/CAP... | Download Table
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.,JAMA Oncology - X-MOL
![PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b66331181b2eafa14b6e478dcc7fced0c7917993/3-Table1-1.png "PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar")
PDF] HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation | Semantic Scholar
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update | Journal of Clinical Oncology
ASCO Guidelines
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
Breast cancer biomarkers, and a new clinical category for HER2 expression | Medical Laboratory Observer
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
2018 ASCO/CAP summary recommendations [original recommendations and... | Download Scientific Diagram
Brittany Harvey on X: "Listen to the latest @ASCO Guidelines podcast episode to hear co-chairs @awolff and @DrKimAllison discuss this ASCO-CAP HER2 testing guideline update with me, including the implications for clinicians
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents - Modern Pathology
